This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

128 * Mon, 8/2/2010, 8:30 AM - 10:20 AM CC-212 (West)
Bayesian Analysis of Clinical Trial Data — Contributed Papers
Biopharmaceutical Section , Section on Bayesian Statistical Science , ENAR
Chair(s): Scott William Miller, CDRH/FDA
8:35 AM A Bayesian Modeling Approach for Safety Data Analysis in Drug Development Yu Gu, Florida State University ; Ke Zhang, Pfizer Inc. ; Liqiang Yang, Pfizer Inc.
8:50 AM Operational Characteristics of a Go/No-Go Decision Rule in an Early Clinical Trial Atalanta Ghosh, Johnson & Johnson ; Jose Carlos Pinheiro, Johnson & Johnson ; Paul Rothenberg, Johnson & Johnson
9:05 AM A Conditional Bayesian Logistic Regression Model (BLRM) with Overdose Control Lu-May Chiang, Novartis Pharmaceuticals Corporation ; Adarsh Joshi, Eli Lilly and Company ; David Ohlssen, Novartis Pharmaceuticals Corporation ; Jyotirmoy Dey, Novartis Pharmaceuticals Corporation
9:20 AM Multivariate Longitudinal Bayesian Imputation for Global Statistical Test, with Applications to Parkinson's Disease Sheng Luo, The University of Texas School of Public Health ; Andrew Lawson, Medical University of South Carolina ; Jordan J. Elm, Medical University of South Carolina ; Barbara C. Tilley, The University of Texas Health Science Center at Houston
9:35 AM EWOC Online: A Novel Web Application for Computing a Bayesian Phase I Design Method for Dose-Finding with Escalation with Overdose Control Dror Berel, Cedars-Sinai Medical Center ; Andre Rogatko, Oschin Comprehensive Cancer Institute
9:50 AM A Multistate Modeling and Prediction of Survival Distribution Using Information on Subject's Tumor Response Over Time Shengyan Hong, MedImmune ; Iiya Lipkovich, Eli Lilly and Company ; Yan Daniel Zhao, Eli Lilly and Company
10:05 AM Floor Discussion

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.